Indication | MeSH | Ontology | ICD-10 | Ph 1 | Ph 2 | Ph 3 | Ph 4 | Other | Total |
---|---|---|---|---|---|---|---|---|---|
Lymphoma | D008223 | — | C85.9 | 1 | 2 | — | — | — | 2 |
Hodgkin disease | D006689 | — | C81 | — | 1 | — | — | — | 1 |
Large-cell lymphoma anaplastic | D017728 | — | C84.6 | — | 1 | — | — | — | 1 |
Primary cutaneous anaplastic large cell lymphoma | D054446 | — | C86.6 | — | 1 | — | — | — | 1 |
Drug common name | IRATUMUMAB |
INN | iratumumab |
Description | Iratumumab (human mab) |
Classification | Antibody |
Drug class | monoclonal antibodies |
Image (chem structure or protein) | |
Structure (InChI/SMILES or Protein Sequence) | — |
PDB | — |
CAS-ID | — |
RxCUI | — |
ChEMBL ID | CHEMBL2108612 |
ChEBI ID | — |
PubChem CID | — |
DrugBank | — |
UNII ID | AYH22O1B1U (ChemIDplus, GSRS) |